China National Medicines Corporation Ltd. (SHA: 600511)
China flag China · Delayed Price · Currency is CNY
34.42
-0.70 (-1.99%)
Nov 13, 2024, 3:00 PM CST

China National Medicines Corporation Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
8,29810,9268,8967,3046,2255,702
Upgrade
Trading Asset Securities
---11.4--
Upgrade
Cash & Short-Term Investments
8,29810,9268,8967,3166,2255,702
Upgrade
Cash Growth
5.72%22.81%21.60%17.53%9.16%11.83%
Upgrade
Accounts Receivable
15,61012,88112,55013,39212,50712,075
Upgrade
Other Receivables
316.43204389.6979.93129.77221.49
Upgrade
Receivables
15,92713,08512,94013,47212,63712,297
Upgrade
Inventory
5,2573,9613,7173,5153,0503,356
Upgrade
Other Current Assets
288.4307.79210.44280.62198.65320.83
Upgrade
Total Current Assets
29,77128,27925,76424,58422,11021,676
Upgrade
Property, Plant & Equipment
897.64827.04857.91845.06895.73832.74
Upgrade
Long-Term Investments
2,0311,9071,6231,3651,141933.49
Upgrade
Goodwill
203.77203.77203.77203.77203.77203.77
Upgrade
Other Intangible Assets
260.2258.11262.92258.65256.12263.78
Upgrade
Long-Term Deferred Tax Assets
142.21123.87124.37115.94100.6106.99
Upgrade
Long-Term Deferred Charges
163.74150.0686.1989.690.3171.81
Upgrade
Other Long-Term Assets
867.13703.57686.95548.08108.13105.06
Upgrade
Total Assets
34,33632,45329,60928,01024,90524,194
Upgrade
Accounts Payable
12,51710,9439,91710,0588,9909,404
Upgrade
Accrued Expenses
103.14604.96640.01564.03514.43611.46
Upgrade
Short-Term Debt
284.32268.35252.06428.83471.83348.92
Upgrade
Current Portion of Leases
87.9474.0880.575.8170.1242.21
Upgrade
Current Income Taxes Payable
130.4113.1784.89112.1876.99107.59
Upgrade
Current Unearned Revenue
107.6561.12176.943.6866.5968.3
Upgrade
Other Current Liabilities
1,3871,8301,5891,4571,0471,021
Upgrade
Total Current Liabilities
14,61713,89412,74012,73911,23711,603
Upgrade
Long-Term Leases
292.34205.08182.57197.29260.09166.62
Upgrade
Long-Term Unearned Revenue
40.6446.0646.3542.6645.5339.54
Upgrade
Long-Term Deferred Tax Liabilities
29.5626.7833.4735.3940.8446.43
Upgrade
Other Long-Term Liabilities
899.32747.14747.14639.8226.62178.07
Upgrade
Total Liabilities
15,88014,92013,75013,65511,81112,035
Upgrade
Common Stock
754.5754.5754.5754.5754.5754.5
Upgrade
Additional Paid-In Capital
2,3492,3492,3492,3492,3492,349
Upgrade
Retained Earnings
13,47912,64211,0879,6528,3127,411
Upgrade
Comprehensive Income & Other
26.2930.7424.0424.9127.6922.45
Upgrade
Total Common Equity
16,60815,77614,21512,78011,44410,537
Upgrade
Minority Interest
1,8481,7571,6451,5751,6501,622
Upgrade
Shareholders' Equity
18,45617,53315,85914,35513,09412,159
Upgrade
Total Liabilities & Equity
34,33632,45329,60928,01024,90524,194
Upgrade
Total Debt
664.61547.5515.13701.93802.04557.75
Upgrade
Net Cash (Debt)
7,63310,3788,3816,6145,4235,144
Upgrade
Net Cash Growth
2.87%23.83%26.72%21.97%5.41%26.29%
Upgrade
Net Cash Per Share
10.1213.7611.118.777.196.75
Upgrade
Filing Date Shares Outstanding
754.5754.5754.5754.5754.5754.5
Upgrade
Total Common Shares Outstanding
754.5754.5754.5754.5754.5754.5
Upgrade
Working Capital
15,15314,38513,02511,84510,87210,073
Upgrade
Book Value Per Share
22.0120.9118.8416.9415.1713.97
Upgrade
Tangible Book Value
16,14415,31413,74812,31810,98410,070
Upgrade
Tangible Book Value Per Share
21.4020.3018.2216.3314.5613.35
Upgrade
Buildings
-408.84433.49387.18381.37388.93
Upgrade
Machinery
-759.8702.78661.15629.64616.3
Upgrade
Construction In Progress
-2.5436.2157.0913.2412.12
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.